covid 19 News and Research

RSS

Two doses of Pfizer-BioNTech SARS-CoV-2 vaccine induce humoral protection against U.K. and S.A. variants

Researchers at the Pitié Salpêtrière Hospital, Department of Virology, Paris, France determined that in BNT162b2-vaccinated participants who received two doses, their sera harbored at least a neutralizing titer against the three SARS-CoV-2 variants.

8 Mar 2021

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants and that the new variants raise the specter that reinfections could be more likely.

8 Mar 2021

Worse problems with SARS-CoV-2 variants may be on the way

Researchers at the Department of Integrative Biomedical Sciences, University of Cape Town, South Africa, found evidence of a significant change in the selective forces acting on immunologically important SARS-CoV-2 genes, such as N and S. These likely coincided with the emergence of the 501Y lineages.

8 Mar 2021

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

The currently developed vaccines against SARS-CoV-2 include the RBD in their immunogen. With a similar objective, a new study developed an RBD protein-based vaccine candidate against the SARS-CoV-2, using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. The study is published recently in the journal mBio (by the American Society of Microbiology).

8 Mar 2021

Negative impact of pandemic reduces people's cognitive capacity

Lockdown and other restrictions imposed to control the COVID-19 pandemic have had unseen negative effects on the cognitive capacity and mental health of the population.

8 Mar 2021

SARS-CoV-2 vaccines modeled on South African variant may offer broad protection against other variants

Researchers in South Africa have submitted evidence that suggests that vaccines modeled on the South African variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) would not only be effective on that strain but would also function well against other variants.

8 Mar 2021

Continued vigilance needed as COVID lockdown is relaxed in England, warn researchers

Researchers have reported findings from round nine of the REal-time Assessment of Community Transmission Study (REACT-1) that estimates community prevalence of infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in England.

8 Mar 2021

Sniffer dogs could be used to detect SARS-CoV-2 infections, say researchers

Researchers in Germany suggest that sniffer dogs should be considered as an additional screening tool for detecting infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

8 Mar 2021

Study: More than 2/3 of Indiana nursing home staff show willingness to receive COVID-19 vaccine

In a study conducted shortly before COVID-19 vaccines became available in the U.S., more than two-thirds of nursing home and assisted living staff in Indiana indicated willingness to receive a vaccine immediately or in the future.

8 Mar 2021

Clinical trial launched to test the effectiveness of mouthwash in reducing COVID-19 spread

Researchers at the University of North Carolina at Chapel Hill Adams School of Dentistry have launched a clinical trial to test whether mouthwash can reduce a person's risk of spreading coronavirus.

8 Mar 2021

Researchers identify new biomarkers associated with severity of COVID-19

A team of researchers from the CHUM Research Centre has identified new biomarkers associated with the severity of COVID-19 in infected patients.

8 Mar 2021

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India -- one of the world's most ethnically diverse countries.

8 Mar 2021

Supplement presents latest evidence on quitlines' effectiveness for smoking termination

While cigarette smoking continues to be the leading cause of preventable disease, disability and death in the U.S., the evidence base for cessation support has revealed that telephone call centers, or "quitlines," have been a particularly successful intervention, according to the Centers for Disease Control and Prevention, which recently published a compilation of scientific research in the American Journal of Preventive Medicine.

8 Mar 2021

Outdoor activities help improve mental health and well-being of teenagers during the pandemic

A study from North Carolina State University found outdoor play and nature-based activities helped buffer some of the negative mental health impacts of the COVID-19 pandemic for adolescents.

8 Mar 2021

Narrowing down on small molecular inhibitors of SARS-CoV-2 key protease

A recent methodological study by researchers from the University of Luxembourg shows that the combination of virtual screening approaches, molecular dynamics simulations and machine learning can substantially facilitate small molecule screening investigations targeted at key SARS-CoV-2 viral proteins.

8 Mar 2021

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Many parents know the struggle of having to make children with pneumonia finish the usual 10-day course in antibiotics despite the child feeling better after a few days of medication.

8 Mar 2021

Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response

A team of scientists from Israel has recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2, in inducing host humoral immune response. The findings reveal that the vaccine is capable of inducing strong anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody response and that the response varies significantly with age. The study is currently available on the medRxiv* preprint server.

8 Mar 2021

covid 19 News and Research

Two doses of Pfizer-BioNTech SARS-CoV-2 vaccine induce humoral protection against U.K. and S.A. variants

Current vaccines and therapies may be less effective at neutralizing new SARS-CoV-2 variants

Worse problems with SARS-CoV-2 variants may be on the way

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

Negative impact of pandemic reduces people's cognitive capacity

SARS-CoV-2 vaccines modeled on South African variant may offer broad protection against other variants

Continued vigilance needed as COVID lockdown is relaxed in England, warn researchers

Sniffer dogs could be used to detect SARS-CoV-2 infections, say researchers

Study: More than 2/3 of Indiana nursing home staff show willingness to receive COVID-19 vaccine

Clinical trial launched to test the effectiveness of mouthwash in reducing COVID-19 spread

Researchers identify new biomarkers associated with severity of COVID-19

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Supplement presents latest evidence on quitlines' effectiveness for smoking termination

Outdoor activities help improve mental health and well-being of teenagers during the pandemic

Narrowing down on small molecular inhibitors of SARS-CoV-2 key protease

Five-day course of high-dose antibiotic will do just as well for children with pneumonia

Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response

Study rethinks the role of ACE2 in SARS-CoV-2 viral entry

Researchers present fragment-based computational design of antibodies that target structured epitopes

Impairments in immune response contribute to severe COVID-19

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News